Standout Papers
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge (1972)
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations (1972)
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders (1967)
Citation Impact
Citing Papers
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
1978
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
1983 StandoutNobel
Electrographic exercise stress testing and coronary arteriography. Correlation among 114 men with chest pain.
1977
Lipoprotein fractionation.
1973
Lipoprotein Electrophoretic Patterns, Serum Lipids, and Coronary Heart Disease
1971
Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment
1993
Electrophoretic separation of plasma lipoproteins in agarose gel
1968
Receptor-mediated low density lipoprotein catabolism in man.
1979
Three-pool model of the long-term turnover of plasma cholesterol in man
1973
Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
1997
Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthoma
1980
Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged
1994
Cigarette Smoking and Progression of Atherosclerosis
1998
Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
2008
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
2014
Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment
1994
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study
1994
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
2014
Comparison of the Safety and Efficacy of a Combination Tablet of Niacin Extended Release and Simvastatin vs Simvastatin Monotherapy in Patients With Increased Non–HDL Cholesterol (from the SEACOAST I Study)
2008
The cardiovascular health study: Design and rationale
1991 Standout
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
2001
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes
2002
Distribution of lipids in 8,500 men with coronary artery disease
1995
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
2002
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Prevalence of risk factors in men with premature coronary artery disease
1991
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
2003
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
2014
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
1994
Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel
1993
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
1993
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Simultaneous Screening for Three Correlated Lipids in the VA HDL Intervention Trial
1999
Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor
1993
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
2002
Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia
2012
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
2015 Standout
Dietary -sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes
1994
Comparison of an Immunoprecipitation Method for Direct Measurement of LDL-Cholesterol With Beta-Quantification (Ultracentrifugation)
1995
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels
1996
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
1992
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Statin-Associated Myopathy
2003
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) study
1995
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
2007
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
1998
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
1997 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
1998
Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
1981
The LDL Receptor Gene: A Mosaic of Exons Shared with Different Proteins
1985 StandoutScienceNobel
Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
1986 StandoutScienceNobel
Very low density lipoprotein “remnant” particles: uptake by aortic smooth muscle cells in culture
1973
Correlation of Electrocardiographic Studies and Arteriographic Findings with Angina Pectoris
1972
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
1974
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 StandoutNatureNobel
Exercise testing in the diagnosis of coronary heart disease: A perspective
1977
GENETICS OF HYPERLIPOPROTEINÆMIAS
1971
Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia
1985
The Metabolic Role of Lecithin: Cholesterol Acyltransferase: Perspectives from Pathology
1973
Atherosclerosis: Scavenger cell receptor shared
1985 StandoutNatureNobel
Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts.
1981
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
1985
Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins
1978
SERUM LIPOPROTEIN PATTERN IN MYOCARDIAL INFARCTION
1970
Studies on the composition and structure of plasma lipoproteins
1972
Catabolism of very low density lipoproteins in the rabbit effect of changing composition and pool size
1978
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Type III Hyperlipoproteinemia: Defective Metabolism of an Abnormal Apolipoprotein E
1981 Science
Treatment of hyperlipidemias
1968
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol
1984
Lipoprotein Uptake and Metabolism by Rat Aortic Smooth Muscle Cells in Tissue Culture
1974
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Transfers and exchanges of esterified cholesterol between plasma lipoproteins
1982
Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease
1979 Standout
Radioimmunoassay of arginine-rich apolipoprotein of rat serum
1977
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.
1975
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia)
1972
Familial Type IV Hyperlipoproteinemia
1969
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: An Approach to Accurate and Precise Lipid Measurements
1989
Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated.
1995
Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia
1974
In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism.
1979
Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin/manganese precipitability.
1977
Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
1968
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Diabetes, Blood Lipids, and the Role of Obesity in Coronary Heart Disease Risk for Women
1977
High-affinity uptake and degradation of acetylated low density lipoprotein by confluent human vascular endothelial cells
1985
Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
1978
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts
1978
Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
1981
Neonatal familial type II hyperlipoproteinemia: Cord blood cholesterol in 1800 births
1971
Structural studies on serum lipoproteins
1972
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
1981
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
1980
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
1980
Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity
1974 StandoutNobel
Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region
1987 StandoutNatureNobel
Atherosclerosis: The low-density lipoprotein receptor hypothesis
1977 StandoutNobel
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
1972
EVOLUTION OF THE LDL RECEPTOR CONCEPT–FROM CULTURED CELLS TO INTACT ANIMALS *
1980 StandoutNobel
Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.
1979
The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats
1977
Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia
2013
Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apollpoproteins
1978
Atherogenesis: a postprandial phenomenon.
1979 Standout
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
1998
Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.
1979
High density lipoprotein as a protective factor against coronary heart disease
1977 Standout
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
PLASMA LIPOPROTEINS AND APOLIPOPROTEINS
1974
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
1973
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
An International Classification of Hyperlipidemias and Hyperlipoproteinemias
1971
Canine Lipoproteins and Atherosclerosis
1974
Declining Serum Total Cholesterol Levels Among US Adults
1993
Familial Hypercholesterolemia: A Genetic Defect in the Low-Density Lipoprotein Receptor
1976
WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemia
1980
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)
1970
Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia
1982
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
1969
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.
1978
Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells.
1985
A Heritable Hyperlipemic Rabbit
1975
Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia
1968
Inhibition of receptor-mediated clearance of lysine and arginine modified lipoproteins from the plasma of rats and monkeys
1980
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Platelet-derived growth factor stimulates low density lipoprotein receptor activity in cultured human fibroblasts.
1980
The status of risk factors and coronary heart disease
1970
Ischemic Heart Disease in Young Adults
1968
Metabolic relationships among the plasma lipoproteins
1972
The metabolism of the apoprotein of plasma low density lipoprotein in familial hype rbetalipoproteinaemia in the homozygous form
1975
The distribution of plasma lipoproteins in middle-aged male runners
1976
The chronology of AIDS research
1987 StandoutNatureNobel
A multivariate approach for interpreting treadmill exercise tests in coronary artery disease.
1978
LIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVES
1972
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
1988
The LDL Receptor Defect in Familial Hypercholesterolemia: Implications for Pathogenesis and Therapy
1982 StandoutNobel
Novel Proteinaceous Infectious Particles Cause Scrapie
1982 StandoutScienceNobel
Lipoprotein lipid alterations with cholestyramine administration.
1970
Typing of hyperlipoproteinaemias
1970
Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia.
1975
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.
1968
NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIA
1973
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
1982 StandoutNobel
Typing of hyperlipoproteinemias
1970
The LDL Pathway in Human Fibroblasts: A Receptor-Mediated Mechanism for the Regulation of Cholesterol Metabolism
1976 StandoutNobel
Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.
1980
Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia
1977
Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.
1975
Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal
1980
Therapeutic effects of ML-236B in primary hypercholesterolemia
1980
Apolipoprotein B variant derived from rat intestine.
1980
Distinct Hepatic Receptors for Low Density Lipoprotein and Apolipoprotein E in Humans
1985 Science
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins.
1972
Serum Lipids in Infection
1969
Polymorphism of apolipoprotein E
1979
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages
1980
Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.
1977
Lipoprotein regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat liver cell cultures.
1977
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
1970 Standout
Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods
1969
Altered Metabolism (In Vivo and In Vitro) of Plasma Lipoproteins after Selective Chemical Modification of Lysine Residues of the Apoproteins
1979
Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period.
1970
Metabolic Studies in Familial Hypercholesterolemia
1979
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
2003
Serum Lipids and Glucose Tolerance in Angiographically Proved Coronary Artery Disease
1970
Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
2012
Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk
1990
A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts
1977 StandoutNatureNobel
Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster.
1983
Lipoprotein uptake by cultured human arterial smooth muscle cells
1975
The interaction of cholesterol absorption and cholesterol synthesis in man
1969
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
1987
The removal of cholesterol from landschütz ascites cells by high-density apolipoprotein
1973
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
1983
Bovine aortic endothelial cells display macrophage-like properties towards acetylated 125I-labelled low density lipoprotein
1980
Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells
1975 StandoutNobel
Detection of individual susceptibility toward coronary disease
1971
Mutation in LDL Receptor: Alu-Alu Recombination Deletes Exons Encoding Transmembrane and Cytoplasmic Domains
1985 StandoutScienceNobel
Familial Hypercholesterolemia in a Large Kindred
1972 StandoutNobel
Ethnic Differences in C-Reactive Protein Concentrations
2008
Binding, interiorization and degradation of cholesterol ester-labelled chylomicron-remnant particles by rat hepatocyte monolayers
1977
Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein.
1980
Aggravation of Broad-ß Disease (Type 3 Hyperlipoproteinemia) by Hypothyroidism
1972
Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in Man
1969
Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet
1971
Value and limitations of the electrocardiographic response to exercise in the assessment of patients with coronary artery disease
1978
Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein
1976
Familial hypercholesterolemia
1975 StandoutNobel
The false positive stress test
1977
Bayesian Analysis of Electrocardiographic Exercise Stress Testing
1977
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques
1968
Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease.
1977
Catabolism of the apoprotein of low density lipoproteins by the isolated perfused rat liver.
1978
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)
2003
Human Serum Lipoproteins and Their Interrelationships
1967
The Pathogenesis of Atherosclerosis
1976 Standout
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
2014
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors.
1980
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
The distribution and composition of serum lipoproteins in eighteen animals
1971
CHOLESTEROL METABOLISM IN MAN
1955
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
1984
Apoprotein (E–A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E–A-II) complex.
1978
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
1985 StandoutNatureNobel
Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
1982
Mechanism of action of gemfibrozil on lipoprotein metabolism.
1985
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
1998
Thickening of the Carotid Wall
1996
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
1984
Assessment of long-term plasma exchange for familial hypercholesterolaemia.
1980
Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.
1981
A radioautographic study of the transport of 125I-labeled serum lipoproteins in rat aorta
1973
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
1981 StandoutNobel
Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia)
1968
Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.
1981 StandoutNobel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 StandoutNobel
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
1972
Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man
1974 StandoutScienceNobel
Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and Diagnosis
1982
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
1998
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus
1980
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
1987
Defective Lipoprotein Receptors and Atherosclerosis
1983
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
1974 StandoutNobel
Works of Robert I. Levy being referenced
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma
1972
Metabolic fate of rat and human lipoprotein apoproteins in the rat
1973
On the lipoprotein abnormality in type III hyperlipoproteinemia
1971
The metabolism of very low density lipoprotein proteins
1972
Secondary prevention and lipid lowering: Results and implications
1985
Hypolipidemic Drugs and Lipoprotein Metabolism
1972
The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
1972 Standout
Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOOD
1974
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein
1973
Diagnoses and management of hyperlipoproteinemia
1968
Cardiovascular pathology in hyperlipoproteinemia
1973
Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine
1973
Hypertriglyceridemia, Diabetes Mellitus, and Coronary Vessel Disease
1969
Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia
1974
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease
1969
Further Characterization of Apolipoproteins from the Human Plasma Very Low Density Lipoproteins
1970
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
1972 Standout
Effects of hyperlipoproteinemias and their treatment on the peripheral circulation
1970
Selective Measurement of Two Lipase Activities in Postheparin Plasma from Normal Subjects and Patients with Hyperlipoproteinemia
1974
Homozygous Familial Hypercholesterolemia
1975
Heterogeneity of Plasma High Density Lipoproteins*
1965
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
The kinetic properties of very low density lipoprote1n triglyceride in type III hyperlipoproteinemia
1973
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Studies of the Proteins in Human Plasma Very Low Density Lipoproteins
1969
High Density Lipoprotein Metabolism in Man
1977
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
1972
Further characterization of the apolipoproteins of rat plasma lipoproteins
1970
On the apoprotein composition of human plasma very low density lipoprotein subfractions
1972
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
Immunoreactive Insulin, Glucose Tolerance, and Carbohydrate Inducibility in Types II, III, IV, and V Hyperlipoproteinemia
1969
Correction of COOH-terminal Amino Acids of Human Plasma Very Low Density Apolipoproteins
1971
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Characterization, Subcellular Localization, and Partial Purification of a Heparin-released Triglyceride Lipase from Rat Liver
1973
Acute Muscular Syndrome Associated with Administration of Clofibrate
1968
The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins.
1972
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967
Total Inhibition of Hepatic β-Lipoprotein Production in the Rat by Orotic Acid
1967
Limitations of the Electrocardiographic Response to Exercise in Predicting Coronary-Artery Disease
1975